Egyptian International Pharmaceutical Industries Co. PHAR
المصرية الدولية للصناعات الدوائية - ايبيكو
Health Care & PharmaceuticalsEgyptian Exchange
115.80 EGP
+1.67%
Close of Thu 1 Oct 2026
- Market value
- EGP 19.54bn
- Highest and lowest close in a year
- 61.45 – 160.18
- Shares traded in the session
- 1,171,718
A chart of every session, the financial statements, the nine checks and filing alerts. Free, with your e-mail and a six-digit code.
About the company
Egyptian International Pharmaceutical Industries (EIPICO) is a pharmaceuticals company based in 10th of Ramadan, Egypt, established in December 1980 and listed on the EGX since September 1995. It is 50.0% owned by the Arab Company for Drug Industries and Medical Appliances - Egypt. It holds majority stakes in Egyptian International Company for Ampoules and EIPICO Tech for Medecines, alongside minority holdings in other pharmaceutical entities.
Its record at the exchange
Between 2010 and 2026, the company generated 569 filings, peaking at 49 filings in 2023. Its trading was suspended 14 times and resumed 13 times. Across 62 reported financial periods from 2014 to 2026, it recorded no loss-making periods. Net results ranged from a low of 89 million EGP in Q1 2015 to a high of 1,458 million EGP in FY 2025. The record includes 3 capital-increase filings.
Its latest filings at the exchange
- ResultsEgyptian International Pharmaceuticals (EIPICO) (PHAR.CA) Reports its Financial Results (Consolidated) for the Period from 01/01/2026 to 30/06/2026
- ResultsEgyptian International Pharmaceuticals (EIPICO) (PHAR.CA) Reports its Financial Results (Standalone) for the Period from 01/01/2026 to 30/06/2026
- Trading resumedResume of Trading on Egyptian International Pharmaceuticals (EIPICO) (PHAR.CA)
- Board decisionsEgyptian International Pharmaceuticals (EIPICO) (PHAR.CA) - Decisions of the Board of Directors
- Trading haltedSuspension of Trading on Egyptian International Pharmaceuticals (EIPICO) (PHAR.CA)
- Release from Egyptian International Pharmaceuticals (EIPICO) (PHAR.CA) Concerning the Stock Price
- Release from Egyptian International Pharmaceuticals (EIPICO) - (PHAR.CA) Regarding a Factory Opening
- Board decisionsEgyptian International Pharmaceuticals (EIPICO) (PHAR.CA) - Disclosure Form for the BoD & the Shareholders' Structure
Insider trades in the exchange’s bulletin
As the exchange publishes them in each session’s bulletin: the trader’s capacity, not their name. Each row opens the bulletin itself.
- Insider / Board Sold1,000 (less than 0.01% of the company)Bulletin ↗
- Insider / Board Sold5,000 (less than 0.01% of the company)Bulletin ↗
- Insider / Board Sold5,000 (less than 0.01% of the company)Bulletin ↗
- Insider / Board Sold2,000 (less than 0.01% of the company)Bulletin ↗
- Insider / Board Sold3,800 (less than 0.01% of the company)Bulletin ↗
- Insider / Board Sold200 (less than 0.01% of the company)Bulletin ↗
Other companies in Health Care & Pharmaceuticals
- GlaxoSmithKline S.A.E. BIOC
- Cleopatra Hospital Company CLHO
- El-Nile Co. for Pharmaceuticals & Chemical Industries NIPH
- Ibnsina Pharma ISPH
- Alexandria New Medical Center Co. AMES
- Tenth of Ramadan Pharmaceutical Industries & Diagnostic-Rameda RMDA
- Minapharm Pharmaceuticals MIPH
- Kahira Pharmaceuticals & Chemical Industries Co. CPCI
- Memphis Pharmaceutical & Chemical Industries MPCI
- Alexandria Company for Pharmaceuticals and Chemical Industries AXPH
- Nozha International Hospital NINH
- October Pharma Co. OCPH
Page updated with the data of 1 Oct 2026.